Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.
about
Prescribing for patients on dialysisEfficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).Neurologic Complications of Chronic Kidney Disease.Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease.Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation.Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.Cardiovascular and Stroke Risk in Japanese Hemodialysis Patients With Atrial Fibrillation.Antithrombotic therapy in end-stage renal disease.Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes.Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study.Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management.Vitamin K antagonist use and mortality in dialysis patients.Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.Medical safety in the care of the person with end-stage kidney disease.Warfarin and the Risk of Death, Stroke, and Major Bleeding in Patients With Atrial Fibrillation Receiving Hemodialysis: A Systematic Review and Meta-Analysis
P2860
Q26752999-B9177E00-6668-4386-B12B-B8BFA3B1F99AQ36069462-779F7B60-CD42-4490-8C07-19A59DC5C228Q36171135-BB8386F6-7A22-4542-AAA8-E4869ED458E1Q36239524-D57F363C-AD96-425D-8EAA-9C1D7289766FQ38529716-2BFE4D82-F405-4182-847D-E2937D24F2BDQ38665579-E5CE946B-8641-4A79-B0E3-6A32B8B76A93Q38683015-67A4ED10-F95E-4584-A31B-B36D1A078868Q38821650-B3416ED1-BB99-4211-9E23-105CAA2AA187Q38838258-B1E31CE8-7F87-4AC3-95DE-F89B11786A78Q39145892-A842ABB1-3215-4796-80F4-A8ABDB480A67Q39329927-3EBD20DB-D156-49FC-A9FC-69C5B05F345AQ40193776-97630BDF-54C3-44BB-A610-14B50028CAFCQ40233256-DC0B4C3D-E897-42EF-9129-0947ACD7EEACQ40252422-A594C750-7D01-4726-B887-ED05CFF26505Q40480109-497ABF3C-9E4A-4866-BFD1-64DEF85A8034Q44928316-072A78D3-02A6-4DDD-8875-22FE16A7C6F3Q47106586-029B657A-C476-42EA-A847-8E9C60D626ABQ47220652-EC7871AF-5AF0-492C-9AC9-81C8A78B715FQ47989402-353ABEBC-DBF3-4C00-9935-5A38FB848215Q48522473-ED6BC202-A7EB-481C-A468-66C7D87F485DQ49384881-0CCF40A9-A0E0-44EA-919D-468777271679Q50002162-A8079DD0-1C08-4EC3-B1D7-45A9613519C2Q50119222-4FD6742F-6D3B-49EA-B7C1-DD2ECC137BA0Q59128204-8A04EC8A-B42F-4B6C-B8E1-567A58842232
P2860
Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@en
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@nl
type
label
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@en
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@nl
prefLabel
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@en
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@nl
P2093
P2860
P50
P356
P1476
Warfarin use, mortality, bleed ...... ents with atrial fibrillation.
@en
P2093
Andrea Stella
Antonio Santoro
Claudio Pozzi
Fabio Badiali
Ferruccio Conte
Giuseppe Bonforte
Maria Grazia Valsecchi
Patrizia Ondei
Silvio Bertoli
Simonetta Genovesi
P2860
P304
P356
10.1093/NDT/GFU334
P407
P577
2014-10-28T00:00:00Z